Sana Biotechnology, Inc.
General ticker "SANA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.0B (TTM average)
Sana Biotechnology, Inc. does not follow the US Stock Market performance with the rate: -3.8%.
Estimated limits based on current volatility of 4.7%: low 2.29$, high 2.52$
Factors to consider:
- Total employees count: 142 (-26.8%) as of 2025
- Top business risk factors: Insufficient capital, Regulatory and compliance, Manufacturing issues, Unproven technology, Clinical trial delays
- Current price 18.9% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.80$, 7.41$]
- 2026-12-31 to 2027-12-31 estimated range: [2.64$, 6.95$]
Financial Metrics affecting the SANA estimates:
- Positive: with PPE of -4.8 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Negative: negative Net income
- Negative: negative Industry operating income (median)
- Negative: 34.41 < Shareholder equity ratio, % of 38.59 <= 42.26
- Negative: negative Industry operating cash flow (median)
- Negative: Industry earnings per price (median), % of -15.99 <= 0
- Negative: Investing cash flow per share per price, % of -3.67 <= -2.60
Short-term SANA quotes
Long-term SANA plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $293.14MM | $272.72MM | $250.32MM |
| Operating Income | $-293.14MM | $-272.72MM | $-250.32MM |
| Non-Operating Income | $9.89MM | $5.96MM | $6.15MM |
| R&D Expense | $261.81MM | $215.67MM | $131.98MM |
| Income(Loss) | $-283.25MM | $-266.76MM | $-244.17MM |
| Net Income(Loss)* | $-283.25MM | $-266.76MM | $-244.17MM |
| Stockholders Equity | $287.51MM | $250.50MM | $160.88MM |
| Assets | $565.30MM | $501.02MM | $416.89MM |
| Operating Cash Flow | $-253.58MM | $-223.15MM | $-143.83MM |
| Capital expenditure | $20.03MM | $33.43MM | $0.94MM |
| Investing Cash Flow | $172.01MM | $17.45MM | $-40.24MM |
| Financing Cash Flow | $31.65MM | $199.75MM | $128.73MM |
| Earnings Per Share** | $-1.46 | $-1.16 | $-0.96 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.